In the course of their life, the average person sleeps for more than 25 years. Along with the its conservation across species, this suggests that sleep is likely to play a vitally important role in normal functioning. However, although great advances have been made in understanding the circadian and homeostatic factors that regulate sleep, there is still much that is unknown about its putative functions. Although it is known to be involved with a broad range of processes (including memory consolidation, neuroprotective actions, hormonal function, and interactions with the cardiovascular and immune systems), ‘sleep’ is really an umbrella term for a heterogeneous set of interacting processes that need to be better characterized and understood.
People vary considerably in their typical quality and quantity of sleep. On one level, brain activity as measured by the electroencephalogram (EEG) is a heritable “fingerprint”, aspects of which correlate with a range of clinical, demographic and cognitive variables. On another level, individuals suffering from disorders of sleep (including sleep apnea, insomnia, hypersomnia and narcolepsy) can exhibit markedly aberrant sleep patterns. The precise genetic basis for most of this clinically meaningful variability is largely unknown, however.
Individual differences in sleep (especially lack of sleep) have been associated with a host of chronic medical conditions including obesity, diabetes, hypertension, heart disease and – ultimately – with shortened life expectancy. For some disorders (e.g. major depressive disorder and bipolar disorder) sleep problems are core clinical features. However, the direction of these associations is typically unclear. Do sleep problems lead to disease, or disease to abnormal sleep? Or does a third factor – such as shared genetic basis – give rise both to the sleep and health phenotypes? Delineating these causal networks will be important because they can provide a basis for identifying targets for intervention and patient stratification.
We are initiating a Program in Sleep and Neuropsychiatric Genetics to tackle some of the questions raised above. Specifically, we will embark on pursuing three broad goals:
To complement the focus on brain activity during sleep in relation to psychiatric disease, we also aim to work synergistically with parallel efforts within BWH focused on different aspects of sleep and physical health. Reflecting this, key members and their research interests are listed below:
As a cross-disciplinary initiative, the Program spans the Departments of Psychiatry and Medicine, and is part of the Division for Sleep and Circadian Disorders. We aim to complement existing strong programs including the Programs in Sleep and Cardiovascular Medicine and Sleep Medicine Epidemiology, and the broader Division of Sleep Medicine, in order integrate a focus on neuropsychiatric outcomes, such that the resulting collaborative research will address more holistically the function of sleep in health and disease.
We will also have a close partnership with the Center for Analysis for Complex Sleep Signals, in which methodological expertise in signal processing and modeling can be brought together with expertise in statistical genetics and epidemiology.